Author

Suha Eleya

The Ohio State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:human· 5 Research Focus:host-pathogen & immune response· 4 Research Focus:drug response / drug discovery· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

Dawei ZhouiD· 5 shared Guillaume N. FichesiD· 5 shared Jinshan HeiD· 5 shared Netty G. SantosoiD· 5 shared Thurbu Tshering Lepcha· 5 shared K.A.S.N. ShanakaiD· 4 shared Jian ZhuiD· 3 shared Youngmin ParkiD· 3 shared

Activity by Year

2025-2026 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersMicrobiology

Dawei ZhouORCID

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Targeted RNA degradation of HIV-1 TAR element at 5'UTR by CRISPR-Cas13X blocks HIV-1 lytic reactivation

Thurbu Tshering Lepcha, Dawei Zhou, Guillaume N. Fiches, Nithya Paruchuri, Jinshan He, Kateepe ASN Shanaka, Yan Liu, Suha Eleya, Netty G. Santoso, Jian Zhu

This study uses CRISPR-Cas13X to target HIV-1 TAR RNA, inhibiting viral reactivation and reducing viral load in infected cells.

bioRxiv · Oct 15, 2026 · PreprintMicrobiology

Inhibition of KDM5A/B promotes antitumor innate immune responses in HHV-8/KSHV-positive B-cell lymphomas

Dawei Zhou, Guillaume N. Fiches, Zhenyu Wu, Suha Eleya, Youngmin Park, Jinshan He, K.A.S.N. Shanaka, Thurbu Tshering Lepcha, Yan Liu, Jason Oliva, Kathryn Anne Lurain, Jae Ung Jung, Jun Qi, Weiqiang Zhao, Jian Zhu, Netty G. Santoso

This study shows that inhibiting KDM5A/B enhances antitumor innate immune responses and induces KSHV lytic reactivation in KSHV-positive B-cell lymphomas.

npj Viruses · Aug 22, 2026Peer-reviewedMicrobiology

Targeting NAT10 Activates Tumor-Intrinsic Immunity and Suppresses Tumor Progression in Head and Neck Squamous Cell Carcinoma

Thurbu Tshering Lepcha, Nithya Paruchuri, Dawei Zhou, Guillaume N. Fiches, Jinshan He, K.A.S.N. Shanaka, Liu Y, Suha Eleya, Nischal Koirala, J F Zhu, Darrion Mitchell, W Zhao, Netty G. Santoso

This study identifies NAT10 as a suppressor of tumor-intrinsic immunity in HNSCC, showing that its inhibition enhances immune responses and suppresses tumor progression.

bioRxiv · Aug 8, 2026 · PreprintCancer Biology

Levosimendan inhibits HIV-1 infection in myeloid cells in the RIOK1-dependent manner

Jinshan He, Jie Ma, Youngmin Park, Dawei Zhou, Xu Wang, Guillaume N. Fiches, K.A.S.N. Shanaka, Thurbu Tshering Lepcha, Yan Liu, Suha Eleya, Netty G. Santoso, Wen-Zhe Ho, Jian Zhu

This study shows that levosimendan inhibits HIV-1 infection in myeloid cells through RIOK1-dependent mechanisms.

bioRxiv · Apr 9, 2026 · PreprintMicrobiology

NAT10 Suppresses RNA Sensing Induced IFN-β Transactivation to Promote Viral Infection via Interfering with IRF3 Activities

Youngmin Park, Jinshan He, Suha Eleya, Zhenyu Wu, Guillaume N. Fiches, Dawei Zhou, Emily G. Watters, Zhiying He, K.A.S.N. Shanaka, Thurbu Tshering Lepcha, Yan Liu, Netty G. Santoso, Jian Kang Zhu

This study shows NAT10 suppresses IFN-β transactivation by inhibiting IRF3, thereby promoting viral infection.

bioRxiv · Sep 1, 2025 · PreprintMicrobiology